Follow
Jee Hyun Kim
Jee Hyun Kim
Professor of Medicine, Seoul National University
Verified email at snu.ac.kr
Title
Cited by
Cited by
Year
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial
SB Kang, JW Park, SY Jeong, BH Nam, HS Choi, DW Kim, SB Lim, ...
The lancet oncology 11 (7), 637-645, 2010
11182010
Predictive and prognostic impact of epidermal growth factor receptor mutation in non–small-cell lung cancer patients treated with gefitinib
SW Han, TY Kim, PG Hwang, S Jeong, J Kim, IS Choi, DY Oh, JH Kim, ...
Journal of clinical oncology 23 (11), 2493-2501, 2005
9682005
Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority …
SY Jeong, JW Park, BH Nam, S Kim, SB Kang, SB Lim, HS Choi, DW Kim, ...
The Lancet Oncology 15 (7), 767-774, 2014
8422014
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy …
YS Hong, BH Nam, K Kim, JE Kim, SJ Park, YS Park, JO Park, SY Kim, ...
The lancet oncology 15 (11), 1245-1253, 2014
3722014
Optimization of patient selection for gefitinib in non–small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt …
SW Han, TY Kim, YK Jeon, PG Hwang, SA Im, KH Lee, JH Kim, DW Kim, ...
Clinical Cancer Research 12 (8), 2538-2544, 2006
3152006
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
AN Seo, HJ Lee, EJ Kim, HJ Kim, MH Jang, HE Lee, YJ Kim, JH Kim, ...
British journal of cancer 109 (10), 2705-2713, 2013
2952013
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
H Seol, HJ Lee, Y Choi, HE Lee, YJ Kim, JH Kim, E Kang, SW Kim, ...
Modern pathology 25 (7), 938-948, 2012
2922012
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
B Keam, SA Im, KH Lee, SW Han, DY Oh, JH Kim, SH Lee, W Han, ...
Breast Cancer Research 13 (2), 1-7, 2011
2672011
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
JW Kim, KH Nam, SH Ahn, DJ Park, HH Kim, SH Kim, H Chang, JO Lee, ...
Gastric cancer 19 (1), 42-52, 2016
2402016
High EGFR gene copy number predicts poor outcome in triple-negative breast cancer
HS Park, MH Jang, EJ Kim, HJ Kim, HJ Lee, YJ Kim, JH Kim, E Kang, ...
Modern pathology 27 (9), 1212-1222, 2014
2292014
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the …
B Keam, SA Im, HJ Kim, DY Oh, JH Kim, SH Lee, EK Chie, W Han, ...
BMC cancer 7 (1), 1-11, 2007
2282007
Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer
DY Kim, JH Kim, SH Lee, TY Kim, DS Heo, YJ Bang, NK Kim
Annals of oncology 14 (3), 383-387, 2003
2232003
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
HE Lee, JH Kim, YJ Kim, SY Choi, SW Kim, E Kang, IY Chung, IA Kim, ...
British journal of cancer 104 (11), 1730-1738, 2011
2072011
Promoter CpG island hypermethylation during breast cancer progression
SY Park, HJ Kwon, HE Lee, HS Ryu, SW Kim, JH Kim, IA Kim, N Jung, ...
Virchows Archiv 458 (1), 73-84, 2011
1882011
Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy
HW Jung, JW Kim, JY Kim, SW Kim, HK Yang, JW Lee, KW Lee, DW Kim, ...
Supportive care in cancer 23 (3), 687-694, 2015
1792015
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
J Rhee, SW Han, DY Oh, JH Kim, SA Im, W Han, I Ae Park, DY Noh, ...
BMC cancer 8 (1), 1-8, 2008
1762008
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
MJ Kim, HS Lee, JH Kim, YJ Kim, JH Kwon, JO Lee, SM Bang, KU Park, ...
BMC cancer 12 (1), 1-10, 2012
1622012
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era
JH Park, YJ Kim, JO Lee, KW Lee, JH Kim, SM Bang, JH Chung, JS Kim, ...
Lung Cancer 76 (3), 387-392, 2012
1612012
The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery
YH Yun, YA Kim, YH Min, S Park, YJ Won, DY Kim, IJ Choi, YW Kim, ...
Annals of oncology 23 (10), 2731-2737, 2012
1582012
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
S Yamamoto, Z Wu, HG Russnes, S Takagi, G Peluffo, C Vaske, X Zhao, ...
Cancer cell 25 (6), 762-777, 2014
1562014
The system can't perform the operation now. Try again later.
Articles 1–20